Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 7 years
- Director since
- 2023
7 years of board service in total across 2 boards, counting each seat separately. Longest: Bicycle Therapeutics plc, 3 years.
Bicycle Therapeutics plc
Director
Syndax Pharmaceuticals Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Feb 7, 2024 | Syndax Pharmaceuticals Inc. | Grant or award | +17,000 | — | — |
| Jan 2, 2024 | Bicycle Therapeutics plc | Grant or award | +12,000 | — | — |
| Feb 2, 2023 | Syndax Pharmaceuticals Inc. | Grant or award | +16,000 | — | — |
| Jan 13, 2023 | Syndax Pharmaceuticals Inc. | Option exercise | +10,000 | $13.58 | $135,800 |
| Jan 13, 2023 | Syndax Pharmaceuticals Inc. | Open-market sale | −10,000 | $27.00 | $270,000 |
| Jan 13, 2023 | Syndax Pharmaceuticals Inc. | Option exercise | +5,000 | $13.58 | $67,900 |
| Jan 13, 2023 | Syndax Pharmaceuticals Inc. | Open-market sale | −5,000 | $27.00 | $135,000 |
| Jan 12, 2023 | Syndax Pharmaceuticals Inc. | Option exercise | +24,000 | $9.47 | $227,280 |
| Jan 12, 2023 | Syndax Pharmaceuticals Inc. | Open-market sale | −24,000 | $26.74 | $641,760 |
| Jan 3, 2023 | Bicycle Therapeutics plc | Grant or award | +11,500 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.